TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q3 2018 13F Holders as of 9/30/2018

Type / Class
Debt / NOTE 2.500% 9/1
Number of holders
29
Total Principal
223M
Shares change
+223M
Total reported value, excl. options
$229M
Value change
+$229M
Put/Call ratio
0
Number of buys
29
Number of sells
0
Price
$1.03
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.